CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...
Phase 3
Budapest, Hungary and 209 other locations
female subjects who are aged 55 to 90 years and have mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis rela...
Phase 3
Budapest, Hungary and 130 other locations
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Budapest, Hungary and 341 other locations
safety and tolerability of KarXT in subjects with psychosis associated with Alzheimer's Disease....
Phase 3
Budapest, Hungary and 366 other locations
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Budapest, Hungary and 384 other locations
Clinical trials
Research sites
Resources
Legal